Received Mar 5, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HIBV | HIB (PEDVAXHIB) | MERCK & CO. INC. | UNK | X028614 | — |
| PNC15 | PNEUMO (VAXNEUVANCE) | MERCK & CO. INC. | 1 | Y005465 | — |
| RV5 | ROTAVIRUS (ROTATEQ) | MERCK & CO. INC. | UNK | Y005878 | — |
No adverse event; calling to report T/E for PEDVAX HIB , ROTATEQ, VAXNEUVANCE that was administered.; This spontaneous report was received from a health care professional referring to a patient, age and gender was not provided. Information regarding the patient's pertinent medical history, drug allergies or reactions, or concomitant medications was not provided. On 20-FEB-2025, the patient was vaccinated with an improperly stored dose of Pneumococcal 15-valent Conjugate (VAXNEUVANCE) injection, for prophylaxis (dose, route of administration, vaccination scheme frequency, anatomical location were not reported, lot number Y005465 with an expiration date on 08-JAN-2027) with a dose of rotavirus vaccine, live, oral, pentavalent (ROTATEQ) oral liquid, for prophylaxis (dose, route of administration, vaccination scheme frequency, anatomical location were not reported, lot number Y005878 with an expiration date on 28-OCT-2025) and with a dose of haemophilus b conjugate vaccine (Meningococcal protein conjugate) (PEDVAXHIB-LIQUID) for prophylaxis (dose, route of administration, vaccination scheme frequency, anatomical location were not reported, lot number X028614 with an expiration date on 07-NOV-2026). The administered dose of the vaccine experienced a temperature excursion 32.0 degrees Fahrenheit for 2 hours and 12minutes.It was not reported if the information was recorded by a data logger or not. There was no adverse effect reported.